Cadrenal Therapeutics Executive Pham Executes Pre-Arranged Stock Sales Amid Pipeline Developments
Cadrenal Therapeutics Inc. (NASDAQ: CVKD) Chairman, Chief Executive Officer, and Interim Chief Financial Officer Quang X. Pham has executed a series of stock sales totaling $13,110. The transactions were conducted through a pre-arranged trading plan, with the executive reducing his direct shareholding while the company simultaneously advances its i…